P. Lapena et al., INCREASED PRODUCTION OF INTERLEUKIN-6 BY T-LYMPHOCYTES FROM PATIENTS WITH MULTIPLE-MYELOMA, Experimental hematology, 24(1), 1996, pp. 26-30
Alterations in T lymphocyte functions may affect other cellular compon
ents of the immune system. Several lymphokines produced by T cells are
involved in the proliferation and differentiation of human B lymphocy
tes. Alterations in the secretion of these molecules may be implicated
in the development of B cell lymphoproliferative diseases. We have in
vestigated the production of interleukin-2 (IL-2) and interleukin-6 (I
L-6) by T lymphocytes from 14 patients with multiple myeloma (MM) and
16 healthy controls. The phenotypical and functional characteristics o
f these T lymphocytes were also studied. The proliferative response to
vegetal lectin phytohemagglutinin (PHA) stimulation was decreased in
T lymphocytes from MM patients (p < 0.01). This defective proliferativ
e response cannot be ascribed to either defective IL-2 production or d
iminished receptor expression, since neither of these parameters showe
d a significant difference between MM patients and healthy controls (p
> 0.05). However, the defective proliferative response of T lymphocyt
es from MM patients was reverted by the addition of saturating amounts
of exogenous IL-2 (p > 0.05) but not by exogenous IL-6 (p < 0.05). Th
e IL-6 production by PHA-stimulated T lymphocytes from the MM patients
was significantly higher than in healthy controls (p < 0.01). We conc
lude that T lymphocytes from MM patients show a functional alteration
with a defective proliferative response to PHA that is reverted by exo
genous addition of IL-2. After lectin stimulation, the production of I
L-2 by T lymphocytes from those patients was normal, while IL-6 secret
ion was increased.